Valuation : Celltrion Pharm, Inc.

Market Cap 4,674B 6,264,837B 4,027B 3,813B 3,456B 6,484B 446,502B 6,517B 45,285B 17,414B 227,161B 17,552B 17,167B 717,803B P/E 2019
166x
P/E 2020 417x
Enterprise Value 4,837B 6,483,698B 4,168B 3,946B 3,577B 6,710B 462,101B 6,744B 46,867B 18,022B 235,096B 18,166B 17,767B 742,879B EV / Sales 2019
9.06x
EV / Sales 2020 38x
Free-Float
44.28%
Yield 2019 *
-
Yield 2020 -
1 day-1.50%
1 week-3.55%
Current month-5.52%
1 month-12.44%
3 months-5.40%
6 months-36.66%
Current year-32.07%
1 week 39,150
Extreme 39150
41,250
1 month 39,150
Extreme 39150
46,250
Current year 37,000
Extreme 37000
78,300
1 year 37,000
Extreme 37000
78,300
3 years 37,000
Extreme 37000
124,463.12
5 years 37,000
Extreme 37000
138,792.87
10 years 13,660.97
Extreme 13660.974887
221,035.48
Manager TitleAgeSince
Chief Executive Officer 61 26/03/2024
Director of Finance/CFO 53 -
Sales & Marketing 55 -
Director TitleAgeSince
Chairman 68 28/03/2025
Chairman 42 26/03/2024
Director/Board Member 61 26/03/2024
Date Insider Type Main position Quantity % Market Cap. Importance
7/5/25 Others 24 0.0001%
7/5/25 Others 127 0.0003%
7/5/25 Exercice 4,500 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
-1.50%-3.55%-25.72%-36.06% 1.31B
-1.13%-3.97%+15.48%+62.77% 46.7B
-1.13%-7.39%+36.30%+109.40% 39.11B
+0.12%-2.09%+7.65%+78.16% 11.66B
-0.53%-2.06%-12.65%+9.75% 11.6B
-0.38%0.00%+19.82%+136.36% 9.19B
+0.32%-2.26%+23.33%+33.23% 7.27B
+0.17%-1.62%+13.53%+211.41% 7.13B
-1.00%-6.83%+33.22%-17.14% 7.15B
-3.13%-4.45%-45.09%+17.23% 5.13B
Average -0.85%-3.07%+6.59%+60.51% 14.63B
Weighted average by Cap. -0.88%-3.62%+17.13%+76.27%

Financials

2019 2020
Net sales 174B 232,585B 149B 142B 128B 241B 16,577B 242B 1,681B 647B 8,433B 652B 637B 26,649B 234B 313,087B 201B 191B 173B 324B 22,314B 326B 2,263B 870B 11,352B 877B 858B 35,872B
Net income 8.6B 11,531B 7.41B 7.02B 6.36B 11.93B 822B 11.99B 83.35B 32.05B 418B 32.31B 31.6B 1,321B 20.94B 28,069B 18.04B 17.08B 15.48B 29.05B 2,000B 29.2B 203B 78.02B 1,018B 78.64B 76.92B 3,216B
Net Debt 149B 199,129B 128B 121B 110B 206B 14,192B 207B 1,439B 554B 7,220B 558B 546B 22,815B 163B 218,861B 141B 133B 121B 227B 15,598B 228B 1,582B 608B 7,936B 613B 600B 25,076B
Logo Celltrion Pharm, Inc.
Celltrion Pharm Inc is a Korea-based company engaged in the manufacture and sale of pharmaceuticals. The Company’s products include hepatotonics, analgesics, antipyretics, anti-inflammatory drugs, antihistamines, respiratory apparatus drugs, circularly system drugs, digestives and stomachic drugs, hormone disease drugs, antibiotics, nutrients, tonics, and other drugs. It also provides ethical drugs and over-the-counter (OTC) drugs. The Company distributes its products in domestic market and overseas markets such as Philippines, Kazakhstan, Cambodia and other Southeast Asia countries.
Employees
328
Date Price Change Volume
11/09/26 KRW 39,400.00 -1.50% 68,916
10/09/26 KRW 40,000.00 -0.62% 78,378
09/09/26 KRW 40,250.00 +0.62% 43,630
08/09/26 KRW 40,000.00 -1.36% 59,182
07/09/26 KRW 40,550.00 -0.73% 43,795
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B
  1. Stock Market
  2. Stocks
  3. A068760 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!